2022 · Diagnostics · open access
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study
Martinelli et al.
The finding, in our words
Self-collected vaginal and first-void urine samples achieved substantial agreement with clinician-collected cervical samples for HPV detection using the BD Onclarity™ assay, with vaginal samples showing 95.3% overall positive agreement (kappa 0.890) and urine samples 90.6% agreement (kappa 0.776) when no clinical cut-off was applied. This supports decentralised, patient-centric cervical screening programmes.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.